Skip to main content

Therapie mit Antikoagulanzien, Plättchenfunktionshemmern und Thrombolytika

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 2828 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. Br. Med. J. 324: 71–86

    Article  Google Scholar 

  • Barthels M, von Depka M (2003) Gerinnungskompendium, Thieme Verlag

    Google Scholar 

  • Coller BS, Anderson K, Weisman HF (1995) New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemost. 74: 302–308

    PubMed  CAS  Google Scholar 

  • Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (2001). Hemostasis and Thrombosis. JB Lippincott, Philadelphia

    Google Scholar 

  • Gent M et al. (1996) A randomised, blind trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329–1339

    Article  CAS  Google Scholar 

  • Hirsh J, O’Donnell M, Weitz JI (2005) New anticoagulants. Blood 105: 453–463

    Article  PubMed  CAS  Google Scholar 

  • Leitlinien der Bundesärztekammer für die Therapie mit Blut und Blutprodukten und Faktorenkonzentraten in der jeweils aktuellen Fassung: http://www.bundesaerztekammer.de/30/Richtlinien/Richtidx/Blutprodukte/Haemo.pdf

    Google Scholar 

  • Pötzsch B und Madlener K (2002) Gerinnungskonsil, Thieme Verlag

    Google Scholar 

  • Schrör K (2000) Ticlopidine and clopidogrel. In: Fergusson III JJ, Chronos NAF, Harrington RA (eds.) Antiplatelet Therapy in Clinical Practice. Martin Dunitz, London, p. 93–111

    Google Scholar 

  • Schrör K (1997) Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin. Thromb. Hemost. 23: 349–356

    Article  PubMed  Google Scholar 

  • Schrör K. (Ed.) (2004) Aspirin-》Resistance《 or 》Non-Responsiveness《. Dr.Schrör Verlag, Frechen

    Google Scholar 

  • Schrör K, Weber A-A (2003) Comparative pharmacology of GPIIb/IIIa antagonists. J. Thromb. Thrombol. 15: 71–80

    Google Scholar 

  • The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy (2004) Chest. 126(3 Suppl)

    Google Scholar 

    Google Scholar 

  • Thiagarajan P, Wu KK (1999) Mechanisms of antithrombotic drugs. Adv. Pharmacol. 46: 297–324

    Article  PubMed  CAS  Google Scholar 

  • Topol EJ, Byzova TV, Plow, EF (1999) Platelet GPIIb-IIIa blockers. Lancet 353: 227–231

    Article  PubMed  CAS  Google Scholar 

  • Warkentin TE and Greinacher A (2004) Heparin-induced thrombocytopenia 3rd edition Marcel Dekker, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Schrör, K., Greinacher, A. (2007). Therapie mit Antikoagulanzien, Plättchenfunktionshemmern und Thrombolytika. In: Lemmer, B., Brune, K. (eds) Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34181-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34181-9_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34180-2

  • Online ISBN: 978-3-540-34181-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics